{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:01:23Z","timestamp":1782745283922,"version":"3.54.5"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jiac.2021.10.017","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T09:21:08Z","timestamp":1635499268000},"page":"339-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tuberculosis during lung cancer treatment-A case series"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8648-2191","authenticated-orcid":false,"given":"Atsuhisa","family":"Tamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9982-3717","authenticated-orcid":false,"given":"Akira","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2021.10.017_bib1","first-page":"17","article-title":"Tuberculosis and lung cancer","volume":"91","author":"Tamura","year":"2016","journal-title":"Kekkaku"},{"key":"10.1016\/j.jiac.2021.10.017_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.resinv.2015.11.001","article-title":"Cumulative incidence of tuberculosis in lung cancer patients in Japan: a 6-year observational study","volume":"54","author":"Suzuki","year":"2016","journal-title":"Respir Investig"},{"key":"10.1016\/j.jiac.2021.10.017_bib3","first-page":"1","article-title":"Latent tuberculosis infection in lung cancer: a retrospective study from a single center","volume":"93","author":"Tamura","year":"2018","journal-title":"Kekkaku"},{"key":"10.1016\/j.jiac.2021.10.017_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/cid\/ciw838","article-title":"Risk of active tuberculosis in patients with cancer: a systematic review and metaanalysis","volume":"64","author":"Cheng","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.10.017_bib5","doi-asserted-by":"crossref","first-page":"28838977","DOI":"10.1183\/13993003.00157-2017","article-title":"Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis","volume":"50","author":"Dobler","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2021.10.017_bib6","first-page":"21","article-title":"Treatment guidelines for latent tuberculosis infection","volume":"89","year":"2014","journal-title":"Kekkaku"},{"key":"10.1016\/j.jiac.2021.10.017_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1440-1843.2008.01282.x","article-title":"Solid-organ malignancy as a risk factor for tuberculosis","volume":"13","author":"Kim","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.jiac.2021.10.017_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000866","article-title":"Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors","volume":"5","author":"Anand","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.jiac.2021.10.017_bib10","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1378\/chest.128.4.2218","article-title":"Clinical characteristics and treatment responses of tuberculosis in patients with malignancy receiving anticancer chemotherapy","volume":"128","author":"Kim","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2021.10.017_bib11","first-page":"415","article-title":"Current epidemiological trend of tuberculosis in Japan","volume":"6","author":"Ohmori","year":"2002","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2021.10.017_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jiac.2013.11.005","article-title":"Mycobacterium tuberculosis infection in cancer patients at a tertiary care cancer center in Japan","volume":"20","author":"Fujita","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2021.10.017_bib13","first-page":"1021","article-title":"Waning of the specific interferon-gamma response after years of tuberculosis infection","volume":"11","author":"Mori","year":"2007","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2021.10.017_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jiac.2019.10.018","article-title":"Recent trends in the incidence of latent tuberculosis infection in Japanese patients with lung cancer: a small retrospective study","volume":"26","author":"Tamura","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2021.10.017_bib15","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/jjco\/hyv088","article-title":"Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project","volume":"45","author":"Hori","year":"2015","journal-title":"Jpn J Clin Oncol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21002907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21002907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:02:49Z","timestamp":1761159769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21002907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1341321X21002907"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.10.017","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberculosis during lung cancer treatment-A case series","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}